{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T19:34:21Z","timestamp":1783539261943,"version":"3.55.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.lungcan.2018.05.021","type":"journal-article","created":{"date-parts":[[2018,5,22]],"date-time":"2018-05-22T12:54:22Z","timestamp":1526993662000},"page":"151-159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["HOXA9 methylation and blood vessel invasion in FFPE tissues for prognostic stratification of stage I lung adenocarcinoma patients"],"prefix":"10.1016","volume":"122","author":[{"given":"Delphine","family":"Lissa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruhide","family":"Ishigame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rintaro","family":"Noro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marguerite J.","family":"Tucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valery","family":"Bliskovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Shema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica A.","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise D.","family":"Bowman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curtis C.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5019-4374","authenticated-orcid":false,"given":"Ana I.","family":"Robles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.lungcan.2018.05.021_bib0005","first-page":"7","article-title":"Cancer statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J. Clin."},{"issue":"5","key":"10.1016\/j.lungcan.2018.05.021_bib0010","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJMoa1102873","article-title":"Reduced lung-cancer mortality with low-dose computed tomographic screening","volume":"365","author":"National Lung Screening Trial Research Team","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.lungcan.2018.05.021_bib0015","doi-asserted-by":"crossref","first-page":"330","DOI":"10.7326\/M13-2771","article-title":"U. S. preventive services task force, screening for lung cancer: U. S. preventive services task force recommendation statement","volume":"160","author":"Moyer","year":"2014","journal-title":"Ann. Intern. Med."},{"issue":"7","key":"10.1016\/j.lungcan.2018.05.021_bib0020","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1097\/JTO.0b013e3181a7716e","article-title":"The International Association for the Study of Lung Cancer Staging Project: prognostic factors and pathologic TNM stage in surgically managed non-small cell lung cancer","volume":"4","author":"Chansky","year":"2009","journal-title":"J. Thorac. Oncol."},{"issue":"6","key":"10.1016\/j.lungcan.2018.05.021_bib0025","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","article-title":"The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM","volume":"17","author":"Edge","year":"2010","journal-title":"Ann. Surg. Oncol."},{"issue":"10","key":"10.1016\/j.lungcan.2018.05.021_bib0030","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.jtho.2016.05.022","article-title":"Adjuvant chemotherapy for patients with T2N0M0 NSCLC","volume":"11","author":"Morgensztern","year":"2016","journal-title":"J. Thorac. Oncol."},{"issue":"2","key":"10.1016\/j.lungcan.2018.05.021_bib0035","first-page":"191","article-title":"Adjuvant chemotherapy in non-small cell lung cancer: state-of-the-art","volume":"4","author":"Artal Cortes","year":"2015","journal-title":"Transl. Lung Cancer Res."},{"issue":"5","key":"10.1016\/j.lungcan.2018.05.021_bib0040","doi-asserted-by":"crossref","first-page":"492","DOI":"10.21037\/tlcr.2016.10.03","article-title":"Methylation analyses in liquid biopsy","volume":"5","author":"Lissa","year":"2016","journal-title":"Transl. Lung Cancer Res."},{"issue":"10","key":"10.1016\/j.lungcan.2018.05.021_bib0045","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/nrc3130","article-title":"A decade of exploring the cancer epigenome \u2013 biological and translational implications","volume":"11","author":"Baylin","year":"2011","journal-title":"Nat. Rev. Cancer"},{"issue":"7","key":"10.1016\/j.lungcan.2018.05.021_bib0050","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1097\/JTO.0000000000000560","article-title":"An integrated prognostic classifier for stage I lung adenocarcinoma based on mRNA, microRNA, and DNA methylation biomarkers","volume":"10","author":"Robles","year":"2015","journal-title":"J. Thorac. Oncol."},{"issue":"13","key":"10.1016\/j.lungcan.2018.05.021_bib0055","doi-asserted-by":"crossref","first-page":"5527","DOI":"10.1073\/pnas.0701059104","article-title":"Homeobox gene methylation in lung cancer studied by genome-wide analysis with a microarray-based methylated CpG island recovery assay","volume":"104","author":"Rauch","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.lungcan.2018.05.021_bib0060","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1515\/CCLM.2011.108","article-title":"Detection of HOXA9 gene methylation in tumor tissues and induced sputum samples from primary lung cancer patients","volume":"49","author":"Hwang","year":"2011","journal-title":"Clin. Chem. Lab. Med."},{"issue":"6","key":"10.1016\/j.lungcan.2018.05.021_bib0065","doi-asserted-by":"crossref","first-page":"559","DOI":"10.4161\/epi.20219","article-title":"Key epigenetic changes associated with lung cancer development: results from dense methylation array profiling","volume":"7","author":"Nelson","year":"2012","journal-title":"Epigenetics"},{"issue":"7","key":"10.1016\/j.lungcan.2018.05.021_bib0070","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1158\/1078-0432.CCR-13-2109","article-title":"Functional identification of cancer-specific methylation of CDO1, HOXA9, and TAC1 for the diagnosis of lung cancer","volume":"20","author":"Wrangle","year":"2014","journal-title":"Clin. Cancer Res."},{"issue":"32","key":"10.1016\/j.lungcan.2018.05.021_bib0075","doi-asserted-by":"crossref","first-page":"4140","DOI":"10.1200\/JCO.2012.48.5516","article-title":"A prognostic DNA methylation signature for stage I non-small-cell lung cancer","volume":"31","author":"Sandoval","year":"2013","journal-title":"J. Clin. Oncol."},{"issue":"22","key":"10.1016\/j.lungcan.2018.05.021_bib0080","doi-asserted-by":"crossref","first-page":"7141","DOI":"10.1158\/1078-0432.CCR-17-1222","article-title":"A panel of novel detection and prognostic methylated DNA markers in primary non-Small cell lung cancer and serum DNA","volume":"23","author":"Ooki","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.lungcan.2018.05.021_bib0085","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00109-014-1181-y","article-title":"HOX genes and their role in the development of human cancers","volume":"92","author":"Bhatlekar","year":"2014","journal-title":"J. Mol. Med. (Berl)"},{"issue":"3","key":"10.1016\/j.lungcan.2018.05.021_bib0090","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ejcts.2003.11.033","article-title":"Invasion of blood vessels as significant prognostic factor in radically resected T1-3N0M0 non-small-cell lung cancer","volume":"25","author":"Gabor","year":"2004","journal-title":"Eur. J. Cardiothorac. Surg."},{"issue":"3","key":"10.1016\/j.lungcan.2018.05.021_bib0095","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/S0022-5223(98)70331-9","article-title":"Angiogenesis as a predictor of survival after surgical resection for stage I non-small-cell lung cancer","volume":"115","author":"Duarte","year":"1998","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"3","key":"10.1016\/j.lungcan.2018.05.021_bib0100","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.lungcan.2008.12.014","article-title":"Accuracy and prognostic impact of a vessel invasion grading system for stage IA non-small cell lung cancer","volume":"65","author":"Hashizume","year":"2009","journal-title":"Lung Cancer"},{"issue":"12","key":"10.1016\/j.lungcan.2018.05.021_bib0105","doi-asserted-by":"crossref","first-page":"e28844","DOI":"10.1371\/journal.pone.0028844","article-title":"Blood vessel invasion as a strong independent prognostic indicator in non-small cell lung cancer: a systematic review and meta-analysis","volume":"6","author":"Wang","year":"2011","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.lungcan.2018.05.021_bib0110","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s40291-017-0278-8","article-title":"Current and emerging applications of droplet digital PCR in oncology","volume":"21","author":"Olmedillas-Lopez","year":"2017","journal-title":"Mol. Diagn. Ther."},{"issue":"25","key":"10.1016\/j.lungcan.2018.05.021_bib0115","doi-asserted-by":"crossref","first-page":"40946","DOI":"10.18632\/oncotarget.16784","article-title":"Identification of serum inflammatory markers as classifiers of lung cancer mortality for stage I adenocarcinoma","volume":"8","author":"Meaney","year":"2017","journal-title":"Oncotarget"},{"issue":"13","key":"10.1016\/j.lungcan.2018.05.021_bib0120","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1158\/1078-0432.CCR-15-2346","article-title":"A novel epigenetic signature for early diagnosis in lung cancer","volume":"22","author":"Diaz-Lagares","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"10","key":"10.1016\/j.lungcan.2018.05.021_bib0125","doi-asserted-by":"crossref","first-page":"e46297","DOI":"10.1371\/journal.pone.0046297","article-title":"Diagnosis of bladder cancer recurrence based on urinary levels of EOMES, HOXA9, POU4F2, TWIST1, VIM, and ZNF154 hypermethylation","volume":"7","author":"Reinert","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.lungcan.2018.05.021_bib0130","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/978-1-59745-522-0_23","article-title":"MethyLight","volume":"507","author":"Campan","year":"2009","journal-title":"Methods Mol. Biol."},{"issue":"14","key":"10.1016\/j.lungcan.2018.05.021_bib0135","doi-asserted-by":"crossref","first-page":"4689","DOI":"10.1093\/nar\/gkn455","article-title":"DNA methylation analysis by digital bisulfite genomic sequencing and digital MethyLight","volume":"36","author":"Weisenberger","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.lungcan.2018.05.021_bib0140","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1755-8794-2-18","article-title":"PrognoScan: a new database for meta-analysis of the prognostic value of genes","volume":"2","author":"Mizuno","year":"2009","journal-title":"BMC Med. Genomics"},{"issue":"13","key":"10.1016\/j.lungcan.2018.05.021_bib0145","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/jnci\/95.13.961","article-title":"p53 mutations and survival in stage I non-small-cell lung cancer: results of a prospective study","volume":"95","author":"Ahrendt","year":"2003","journal-title":"J. Natl. Cancer Inst."},{"issue":"7","key":"10.1016\/j.lungcan.2018.05.021_bib0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0159601","article-title":"MiR-9 acts as an OncomiR in prostate cancer through multiple pathways that drive tumour progression and metastasis","volume":"11","author":"Seashols-Williams","year":"2016","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.lungcan.2018.05.021_bib0155","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s12094-013-1106-1","article-title":"Up-regulation of miR-9 expression as a poor prognostic biomarker in patients with non-small cell lung cancer","volume":"16","author":"Xu","year":"2014","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.lungcan.2018.05.021_bib0160","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.biopha.2017.11.105","article-title":"MiR-9-5p promotes cell growth and metastasis in non-small cell lung cancer through the repression of TGFBR2","volume":"96","author":"Li","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.lungcan.2018.05.021_bib0165","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s11658-017-0053-1","article-title":"TGF-beta1-induced epithelial-mesenchymal transition in lung cancer cells involves upregulation of miR-9 and downregulation of its target E-cadherin","volume":"22","author":"Wang","year":"2017","journal-title":"Cell. Mol. Biol. Lett."},{"issue":"9","key":"10.1016\/j.lungcan.2018.05.021_bib0170","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1111\/jcmm.13120","article-title":"MiR-9 is involved in TGF-beta1-induced lung cancer cell invasion and adhesion by targeting SOX7","volume":"21","author":"Han","year":"2017","journal-title":"J. Cell. Mol. Med."},{"issue":"17","key":"10.1016\/j.lungcan.2018.05.021_bib0175","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.1002\/cncr.27392","volume":"118","author":"Quillien","year":"2012","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.lungcan.2018.05.021_bib0180","doi-asserted-by":"crossref","first-page":"E32","DOI":"10.1093\/nar\/28.8.e32","article-title":"MethyLight: a high-throughput assay to measure DNA methylation","volume":"28","author":"Eads","year":"2000","journal-title":"Nucleic Acids Res."},{"issue":"8","key":"10.1016\/j.lungcan.2018.05.021_bib0185","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nrc.2016.56","article-title":"Biomarker development in the precision medicine era: lung cancer as a case study","volume":"16","author":"Vargas","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.lungcan.2018.05.021_bib0190","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.lungcan.2016.06.003","article-title":"Integration of multiple OMIC biomarkers: a precision medicine strategy for lung cancer","volume":"107","author":"Robles","year":"2017","journal-title":"Lung Cancer"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500218303866?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500218303866?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T12:30:37Z","timestamp":1759235437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500218303866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":38,"alternative-id":["S0169500218303866"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2018.05.021","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HOXA9 methylation and blood vessel invasion in FFPE tissues for prognostic stratification of stage I lung adenocarcinoma patients","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2018.05.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}